Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease-Reference-Cited by-同舟云学术

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease

Published:2021-01-15 Issue:2 Volume:203 Page:245-249
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Gallay Laure¹,Uzunhan Yurdagül²,Borie Raphael³,Lazor Romain⁴,Rigaud Pierre⁵,Marchand-Adam Sylvain⁶,Hirschi Sandrine⁷,Israel-Biet Dominique⁸,Valentin Victor⁹,Cottin Vincent¹^ORCID

Affiliation:

1. Hospices Civils de Lyon and Université Claude Bernard Lyon 1Lyon, France

2. Assistance Publique-Hôpitaux de Paris and Université Sorbonne Paris NordBobigny, France

3. Assistance Publique-Hôpitaux de Paris Hôpital Bichat and UniversitéBichat-Claude BernardParis, France

4. Lausanne University Hospital and University of LausanneLausanne, Switzerland

5. Assistance Publique-Hôpitaux de Paris Hôpital Tenon and SorbonneUniversitéParis, France

6. Centre Hospitalier Universitaire de ToursTours, France

7. Hôpitaux Universitaires de StrasbourgStrasbourg, France

8. Hôpital Européen Georges PompidouParis, Franceand

9. Centre Hospitalier Régional Universitaire de LilleLille, France

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference12 articles.

1. Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic

2. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

3. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

4. SARS-CoV-2 infection among patients with systemic autoimmune diseases

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with interstitial lung disease;COVID-19: An Update;2024-09-01

2. Impact of the coronavirus disease 2019 pandemic on hospital admissions for idiopathic pulmonary fibrosis: a nationwide population-based study;BMC Pulmonary Medicine;2024-08-31

3. Challenges in the management of idiopathic pulmonary fibrosis from a low- and middle-income country;Journal of the Pakistan Medical Association;2024-05-24

4. Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service;PLOS ONE;2024-03-14

5. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study;Respiratory Research;2024-02-21